VONa Communications VONa Communications

    Subscribe for Updates

    Get the latest news from Voice of Naija about Politics, current affairs, Sports, business etc.

    What's Hot

    Naira Marley, Sam Larry Make First Appearance After Release From Custody

    November 29, 2023

    Kyari Speaks On Reappointment As NNPCL GCEO

    November 29, 2023

    JAMB Announces Dates For 2024 UTME Registration, Examination

    November 29, 2023

    Uefa Champions League: Galatasaray Vs Manchester United

    November 29, 2023
    Facebook Twitter Instagram
     VONa Communications VONa Communications
    • Get In Touch
    Facebook Twitter Instagram
    SUBSCRIBE
    • Home
    • Politics
    • Business & Economy
    • Celebrity News
    • Sports
    • World News
      • Across Africa
      • US News
      • UK News
      • Europe
      • Asia News
    • Across Nigeria
    • More
      • Current Affairs
      • Education
      • Fashion
      • Press Release
      • Opinion
     VONa Communications VONa Communications
    Home»Health»NAFDAC Approves R21 Malaria Vaccine For Children From 5months
    Health

    NAFDAC Approves R21 Malaria Vaccine For Children From 5months

    Alexandra Dominic-ChukwuBy Alexandra Dominic-ChukwuApril 17, 2023Updated:April 17, 2023No Comments1 Min Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    ENUGU, Nigeria (VOICE OF NAIJA) – The National Agency for Food and Drug Administration and Control, (NAFDAC) has announced that it has given approval for the use of the R21 malaria vaccine produced by the Serum Institute of India.

    Professor Mojisola Adeyeye, Director General of the agency, made the disclosure in a press briefing on Monday in Abuja.

    This is coming a few days after Ghana approved the malaria vaccine developed at the University of Oxford.

    The NAFDAC Director noted that the vaccine is indicated for the prevention of clinical malaria in children within the age of 5 months to 36 months.

    She further revealed that the country expects to get at least 100,000 doses of the new vaccine in donations before the market authorization makes other arrangements, particularly with the National Primary Health Care Development Agency.

    Adeyeye said: “NAFDAC in exercising its mandate as stipulated by its enabling law, NAFDAC Act CapN1, LFN 2004 is granting registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted) manufactured by Serum Institute of India Pvt. Ltd.

    “The malaria vaccine is indicated for the prevention of clinical malaria in children from 5 months to 36 months of age.”

    National Agency for Food and Drug Administration and Control (NAFDAC) Professor Mojisola Adeyeye R21 Malaria Vaccine
    Previous ArticleLagos Flood Sweeps Away Four-Year-Old Boy
    Next Article I Made My First Million At 17, Handed It To My Mother – Singer Rema
    Alexandra Dominic-Chukwu

    Alexandra Dominic-Chukwu is based in the eastern region of Nigeria. She covers politics, news writing, feature stories, among others. She has multitasking skills and can easily adapt to any working condition. She enjoys reading and writing.

    Related Posts

    Frozen Chicken Imports Threat To Poultry Sector – PAN

    November 2, 2023

    Enugu Deputy Gov Advises Women To Embrace HPV Vaccine For Healthier Future

    November 1, 2023

    Cleric Advocates Free Medical Outreach For The Needy

    October 29, 2023

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Advertise with us
    Follow Us
     VONa Communications
    Facebook Twitter Instagram YouTube
    • Contact
    • Authors
    © 2023© VONa Communications. All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.